(Q30489890)

English

An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1. (English)

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

John Cogswell

1

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

H David Inzunza

2

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Qiuyan Wu

3

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

John N Feder

4

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Gabe Mintier

5

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

James Novotny

6

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Diana M Cardona

7

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 September 2016

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Molecular Diagnosis and Therapy

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

21

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

1

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

85-93

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

26 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Programmed death ligand-1 expression in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Overall survival and PD-L1 expression in metastasized malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5250639

20 June 2018

Programmed death-ligand 1 (PD-L1) expression in various tumor types

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0237-9

21 January 2018

Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0237-9

21 January 2018

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0237-9

21 January 2018

Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27667773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27667773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40291-016-0237-9

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

26 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30489890&oldid=2194902569"